The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
2
- 1
Mr Ben Mccormack
Born in January 1976Individual (1 offspring)Person with significant control
2024-04-06 ~ nowPE - Ownership of shares – 75% or more → CIF 0PE - Ownership of voting rights - 75% or more → CIF 0PE - Right to appoint or remove directors → CIF 0 - 2
Wilson, James Matthew, Dr
Doctor born in July 1979Individual (1 offspring)Officer 2020-11-09 ~ nowOF - Director → CIF 0Dr James Matthew Wilson
Born in July 1979Individual (1 offspring)Person with significant control 2020-11-09 ~ nowPE - Right to appoint or remove directors → CIF 0
Company in focus
LONDON CANCER CARE LTD
Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Par Value of Share
Class 1 ordinary share
12022-10-01 ~ 2023-09-30
Turnover/Revenue
80,076 GBP2022-10-01 ~ 2023-09-30
29,712 GBP2021-10-01 ~ 2022-09-30
Administrative Expenses
30,261 GBP2022-10-01 ~ 2023-09-30
21,494 GBP2021-10-01 ~ 2022-09-30
Profit/Loss on Ordinary Activities Before Tax
49,815 GBP2022-10-01 ~ 2023-09-30
8,218 GBP2021-10-01 ~ 2022-09-30
Tax/Tax Credit on Profit or Loss on Ordinary Activities
9,223 GBP2022-10-01 ~ 2023-09-30
1,570 GBP2021-10-01 ~ 2022-09-30
Profit/Loss
40,592 GBP2022-10-01 ~ 2023-09-30
6,648 GBP2021-10-01 ~ 2022-09-30
Property, Plant & Equipment
6,500 GBP2023-09-30
6,000 GBP2022-09-30
Debtors
6,025 GBP2023-09-30
6,550 GBP2022-09-30
Cash at bank and in hand
24,297 GBP2023-09-30
27,642 GBP2022-09-30
Current Assets
30,322 GBP2023-09-30
34,192 GBP2022-09-30
Creditors
Current
17,910 GBP2023-09-30
13,872 GBP2022-09-30
Net Current Assets/Liabilities
12,412 GBP2023-09-30
20,320 GBP2022-09-30
Total Assets Less Current Liabilities
18,912 GBP2023-09-30
26,320 GBP2022-09-30
Equity
Called up share capital
100 GBP2023-09-30
100 GBP2022-09-30
Retained earnings (accumulated losses)
18,812 GBP2023-09-30
26,220 GBP2022-09-30
Equity
18,912 GBP2023-09-30
26,320 GBP2022-09-30
Wages/Salaries
5,400 GBP2022-10-01 ~ 2023-09-30
3,800 GBP2021-10-01 ~ 2022-09-30
Average Number of Employees
22022-10-01 ~ 2023-09-30
22021-10-01 ~ 2022-09-30
Property, Plant & Equipment - Depreciation Expense
Owned assets
1,626 GBP2022-10-01 ~ 2023-09-30
1,204 GBP2021-10-01 ~ 2022-09-30
Current Tax for the Period
9,200 GBP2022-10-01 ~ 2023-09-30
1,575 GBP2021-10-01 ~ 2022-09-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
6,750 GBP2023-09-30
4,787 GBP2022-09-30
Computers
3,836 GBP2023-09-30
3,673 GBP2022-09-30
Property, Plant & Equipment - Gross Cost
10,586 GBP2023-09-30
8,460 GBP2022-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
2,250 GBP2023-09-30
1,287 GBP2022-09-30
Computers
1,836 GBP2023-09-30
1,173 GBP2022-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
4,086 GBP2023-09-30
2,460 GBP2022-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
963 GBP2022-10-01 ~ 2023-09-30
Computers
663 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,626 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment
Plant and equipment
4,500 GBP2023-09-30
3,500 GBP2022-09-30
Computers
2,000 GBP2023-09-30
2,500 GBP2022-09-30
Trade Debtors/Trade Receivables
Current
4,550 GBP2023-09-30
4,050 GBP2022-09-30
Prepayments
Current
1,475 GBP2023-09-30
2,500 GBP2022-09-30
Debtors
Current, Amounts falling due within one year
6,025 GBP2023-09-30
6,550 GBP2022-09-30
Corporation Tax Payable
Current
10,798 GBP2023-09-30
1,575 GBP2022-09-30
Accrued Liabilities
Current
1,620 GBP2023-09-30
1,320 GBP2022-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2023-09-30
Profit/Loss
Retained earnings (accumulated losses)
40,592 GBP2022-10-01 ~ 2023-09-30
Dividends Paid
Retained earnings (accumulated losses)
-48,000 GBP2022-10-01 ~ 2023-09-30
Related profiles found in government register
- Registered number 13005459
LONDON CANCER CARE LTD
Info
Flat 21 Rupert House, Nevern Square, London SW5 9PLPrivate Limited Company incorporated on 2020-11-09 (4 years 8 months). The company status is Active.The last date of confirmation statement was made at 2024-11-08CIF 0 LONDON CANCER CARE LTD
SRegistered number 13005459CIF 1Suite L3, South Fens Business Centre, Chatteris, Cambridgeshire, England, PE16 6TTLONDON CANCER CARE LTD
SRegistered number 13005459Suite L3, South Fens Business Centre, Chatteris, Cambridgeshire, England, PE16 6TTIncorporated in United KingdomCIF 2
Offspring entities and appointments
Active
1
- Suite L3, South Fens Business Centre, Chatteris, Cambridgeshire, EnglandActive Corporate (5 parents)Person with significant control 2024-06-23 ~ nowCIF 2 - Ownership of voting rights - More than 25% but not more than 50% → OECIF 2 - Right to surplus assets - More than 25% but not more than 50% → OECIF 2 - Right to appoint or remove members → OEOfficer 2024-06-23 ~ nowCIF 1 - LLP Designated Member → ME
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and
licensed under the Open Government Licence v3.0.